CFDE Data Portal | Search RPL21P85

	Label	Description
	RPL21P85 Gene (Entity type)	ENSG00000231804 - ribosomal protein L21 pseudogene 85
	GSE114492 GSE153671 KMT2D inhibition 6 v 8 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE114492 GSE153671 KMT2D inhibition 12 v 8 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE111247 temozolomide LN-308 0 v 6 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE126258 GSE126739 c-Myc inhibition 1 v 0 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE230865 EYA2 knockdown 1 v 0 human up Gene Set (Entity type)	A Gene Set from LINCS
	GTEx Breast 20-29 vs 30-39 Down Gene Set (Entity type)	A Gene Set from GTEx
	GSE246983 CDK12 knockdown LNCaP C4-2 Cyclin-Dependent Kinases 1 v 0 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE99503 GSK3 TUNAR inhibition B cell 0 v 3 human up Gene Set (Entity type)	A Gene Set from LINCS

RPL21P85

ENSG00000231804 - ribosomal protein L21 pseudogene 85

GSE114492 GSE153671 KMT2D inhibition 6 v 8 human up

A Gene Set from LINCS

GSE114492 GSE153671 KMT2D inhibition 12 v 8 human dn

A Gene Set from LINCS

GSE111247 temozolomide LN-308 0 v 6 human dn

A Gene Set from LINCS

GSE126258 GSE126739 c-Myc inhibition 1 v 0 human up

A Gene Set from LINCS

GSE230865 EYA2 knockdown 1 v 0 human up

A Gene Set from LINCS

GTEx Breast 20-29 vs 30-39 Down

A Gene Set from GTEx

GSE246983 CDK12 knockdown LNCaP C4-2 Cyclin-Dependent Kinases 1 v 0 human dn

A Gene Set from LINCS

GSE99503 GSK3 TUNAR inhibition B cell 0 v 3 human up

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.